Network origin in Ingo Ringshausen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Stroma Biosciences Ltd.
Stroma Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Stroma Biosciences Ltd. is a biopharmaceutical company based in Cambridge, UK. Stroma Biosciences is focused on developing novel anti-stromal therapies to treat cancer by targeting survival signals in the tumour stroma, thereby cutting this important lifeline for cancer cells. The British company's work is focused on mesenchymal stroma cells, which are essential for tumour growth and resistance to cancer therapies. Stroma Biosciences has developed a platform to develop novel first-in-class cancer therapeutics by targeting the stromal compartment. The company has a validated disease-activated platform screening primary tumour samples, and its emerging pipeline includes several stromal targets to treat both solid and haematological malignancies. The company was founded in 2020 by Ingo Ringshausen, Andrew Douglas Moore, and Clive Stanway.
5
| Holding Company | Miscellaneous Commercial Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ingo Ringshausen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Pneumagen (Holdings) Ltd. | Director/Board Member | ||
MEDIVIR AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Atelerix Ltd.
Atelerix Ltd. Electronic Equipment/InstrumentsElectronic Technology Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Investment Managers | Consultant / Advisor | |
The University of Nottingham | College/University | Undergraduate Degree | |
Imperial College London | College/University | Doctorate Degree | |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
BioMoti Ltd.
BioMoti Ltd. Hospital/Nursing ManagementHealth Services BioMoti Ltd. provides cancer treatment and health care services. It offers a new class of immunotherapeutic drug-loaded particles that target and gain entry to the tumor vasculature and cancer cells. The company was founded by Joanne Martin and Davidson Ateh on June 6, 2009 and is headquartered in London, the United Kingdom. | Hospital/Nursing Management | Chairman | |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | Miscellaneous Commercial Services | Chairman | |
University of the Witwatersrand | College/University | Doctorate Degree | |
Pneumagen Ltd.
Pneumagen Ltd. BiotechnologyHealth Technology Pneumagen Ltd. is engaged in biotechnology services. The company was founded in 2016 and is headquartered in Fife, the United Kingdom. | Biotechnology | Director/Board Member | |
Glaxo SmithKline Consumer Healthcare Ltd.
Glaxo SmithKline Consumer Healthcare Ltd. Medical DistributorsDistribution Services GlaxoSmithKline Consumer Healthcare manufactures and supplies over the counter drugs. It focuses on oral healthcare, over the counter medicines and nutritional healthcare products. Its brands and products include oral care (Aquafresh) to dermatology (Zovirax), with all kinds of analgesics (Panadol), gastrointestinal remedies (Tums) and smoking-cessation products (Nicoderm). The company is headquartered in Brentford, UK | Medical Distributors | Corporate Officer/Principal | |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Founder | |
London Business School | College/University | Masters Business Admin | |
Pfizer Group Ltd.
Pfizer Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Group Ltd. is a British company that manufactures and sells pharmaceuticals, animal health products, and healthcare products. The company is based in Sandwich, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree |
Statistics
International
United Kingdom | 20 |
Sweden | 2 |
South Africa | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 6 |
Commercial Services | 4 |
Electronic Technology | 2 |
Finance | 2 |
Operational
Director/Board Member | 7 |
Corporate Officer/Principal | 7 |
Founder | 4 |
Chairman | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Most connected contacts
Insiders | |
---|---|
John Beadle | 13 |
Clive Stanway | 8 |
Paul Wallace | 3 |
Andrew Moore | 1 |
Michale Bouskila-Chubb | 1 |
- Stock Market
- Insiders
- Ingo Ringshausen
- Company connections